mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.006 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.006 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.006 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |